(Total Views: 388)
Posted On: 04/13/2019 3:49:43 AM
Post# of 149265
I will post this here, since it includes great results I just saw. I posted a response to HomeBrew on iHub. Homebrew, you don’t want posting, he knows the ihub rules and will manipulate them to bash a stock 24\7 all day every day. He first posts a few times on a board, enough to be made mod with the help of ihub admin, then the heavy bashing begins, usually with also modifying the ihub box with a big flashing warning. He mods 32 boards and is on the secret modsquad ihub crew, hidden mods to every board.
(about the rumormill being wrong, Homebrew: “LOLOL...That nonsense site loves trolling OTC. ”
Me: Yeah, Chicago is a dead giveaway, with the number of trips NP has made to NY in the last 3 months, NYC would have made it more believable.
Also, if they had said something about cancer in the acquisition.
I mean look at this data just published a couple weeks ago, the 5 year survival rate for stage III, IV for colorectal cancer with low ccr5 expression was 70% and the high ccr5 expression just 10%, p value .001. Cytodyn holding the ccr5/cancer patents and this year being the one many in the medical field are learning of this connection, you would think they could come up with a better rumor.
https://www.nature.com/articles/s41419-019-1508-2
(about the rumormill being wrong, Homebrew: “LOLOL...That nonsense site loves trolling OTC. ”
Me: Yeah, Chicago is a dead giveaway, with the number of trips NP has made to NY in the last 3 months, NYC would have made it more believable.
Also, if they had said something about cancer in the acquisition.
I mean look at this data just published a couple weeks ago, the 5 year survival rate for stage III, IV for colorectal cancer with low ccr5 expression was 70% and the high ccr5 expression just 10%, p value .001. Cytodyn holding the ccr5/cancer patents and this year being the one many in the medical field are learning of this connection, you would think they could come up with a better rumor.
https://www.nature.com/articles/s41419-019-1508-2
(2)
(0)
Scroll down for more posts ▼